Cargando…
High HBV Load Weakens Predictive Effect of Serum miR-122 on Response to Sorafenib in Hepatocellular Carcinoma Patients
BACKGROUND: MiR-122 is a liver-specific microRNA. The aim of the study was to explore the association of serum miR-122 with response to sorafenib in hepatitis B virus- (HBV-) related hepatocellular carcinoma (HCC) patients and to further reveal the effect of the virus load on such potential relation...
Autores principales: | Zhang, Xiaomin, Wang, Fu'an, Gu, Guangfeng, Wu, Qingpo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214498/ https://www.ncbi.nlm.nih.gov/pubmed/34194500 http://dx.doi.org/10.1155/2021/9938207 |
Ejemplares similares
-
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
por: Turato, Cristian, et al.
Publicado: (2019) -
miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics
por: Fu, Xiao, et al.
Publicado: (2018) -
Clinical significance of combined circulating TERT promoter mutations and miR-122 expression for screening HBV-related hepatocellular carcinoma
por: Trung, Ngo Tat, et al.
Publicado: (2020) -
Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
por: Amr, Khalda S., et al.
Publicado: (2017) -
Synergistic anticancer effects of nanocarrier loaded with berberine and miR-122
por: Li, Lei, et al.
Publicado: (2018)